B Share Buy-back and Total Voting Rights

Transaction in Own Shares and Total Voting Rights and Capital

20 November 2023

Seneca Growth Capital VCT Plc (“The Company”)

The Board of Seneca Growth Capital VCT Plc announces that on 17 November 2023 the Company purchased for cancellation 88,431 B Ordinary Shares of 1p at a gross price of 70.68p per share.

In accordance with the FCA's Disclosure and Transparency Rules sourcebook transitional provision 6, the Company advises that, following this purchase for cancellation, its capital consists of 20,729,286 B Ordinary Shares of 1p each and 8,115,376 Ordinary Shares of 1p each.

The Company does not hold any shares in Treasury.

Therefore, the total number of voting rights in the Company is 28,844,662 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

The Company was satisfied that all inside information which the Directors and the Company were previously in receipt of had become publicly available prior to the market purchase being completed. Therefore, the Company was not prohibited from dealing in its own securities.

For further information, please contact:

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

Bioscience Vct (LSE:BVP)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024